IgG-guided diet outperforms sham diet in clinical trial
Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to ...
Armed robbery in Revesby3d
Immunoglobulin Sales Drive Strong First Half For CSL
CSL (ASX:CSL) has reported a net profit after tax of $2.01 billion for the six months to the ned of December 2024, up 7 per ...
KORU Medical Systems Has A Long Runway
The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...
Koru announces pact for next-gen subcutaneous immunoglobulin infusion system
Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...
independent.co.ug9d
IGG sets March 2025 for politicians’ wealth declaration
The Inspector General of Government (IGG), Beti Olive Kamya Turwomwe, has announced that all politicians in Uganda must ...
UBS Sticks to Their Buy Rating for IG Group Holdings (IGG)
UBS analyst Haley Tam maintained a Buy rating on IG Group Holdings (IGG – Research Report) today and set a price target of p1,150.00. The ...
PNI Atlantic News on MSN7d
How police cracked a decades-old cold case with DNA and charged NL man with murder
A 50-year-old Gander man has been charged in Toronto for the 1998 murder of a young pregnant woman, after police there used DNA from the scene and investigative genetic genealogy to crack the cold ...
ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add
ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...
Morningstar8d
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin (SCIg) therapy infusion system for use with a commercialized ...